Forum
U.S. Court of Appeals for the Seventh Circuit
Case Status
Decided
Docket Number
17-3030
Oral Argument Date
May 30, 2018
Case Updates
Seventh Circuit reverses $3 million verdict against GlaxoSmithKline, concluding plaintiffs’ negligent failure to warn claims were preempted by federal law
August 22, 2018
Click here to view the opinion.
U.S. Chamber argues that Illinois law does not recognize “innovator liability” theory for manufacturers of FDA approved medication
January 29, 2018
Click here to view the amicus brief filed by the U.S. Chamber, American Tort Reform Association, Product Liability Advisory Council, Inc., National Association of Manufacturers, and Illinois Chamber of Commerce.
Kannon K. Shanmugam and Amy Mason Saharia of Williams & Connolly LLP served as co-counsel for the amici.
Case Documents
- Opinion and Order -- Dolin v. GlaxoSmithKline LLC (USDC - Northern District of Illinois).pdf
- Brief of Appellant GSK -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- U.S. Chamber Amicus Brief -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- WLF Amicus Brief -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- PhRMA Amicus Brief -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- Brief of Plaintiff-Appellee -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- AARP Amicus Brief -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- AAJ Amicus Brief -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- Public Citizen Amicus Brief -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- Reply Brief of Appellant GSK -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- GSK 28(j) Letter -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- Plaintiff 28(j) Letter re Rafferty -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- 28(j) Letter (McNair) -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf
- Opinion -- Dolin v. GlaxoSmithKline LLC (Seventh Circuit).pdf